脓毒症风险与死亡率的炎症蛋白特征:一项孟德尔随机化研究
研究采用两样本孟德尔随机化方法,利用11个队列14,824名欧洲参与者的全基因组关联研究荟萃分析获取循环炎症蛋白的遗传工具,并用英国生物银行50万以上欧洲参与者的汇总数据评估脓毒症相关结局。结果显示遗传预测的β-NGF升高与脓毒症风险降低相关(OR 0.77,95%CI 0.60-0.99),在75岁以下脓毒症患者中风险降低30%(OR 0.70,95%CI 0.52-0.93);TRAIL(OR 1.11)和VEGF-A(OR 1.18)升高与脓毒症发病正相关,CST5(OR 0.81)和MCP-1(OR 0.64)升高与脓毒症诱导死亡负相关。作者认为这些发现支持特定循环炎症蛋白在脓毒症风险和死亡率中的因果作用,并提示靶向这些蛋白的治疗干预潜力,同时需进一步研究其机制和临床意义。
要点
- 遗传预测的β-NGF升高与脓毒症风险降低相关(OR 0.77,95%CI 0.60-0.99,P=0.039)。
- 在75岁以下脓毒症患者中,遗传预测的β-NGF升高与风险降低30%相关(OR 0.70,95%CI 0.52-0.93,P=0.013)。
- 遗传预测的TRAIL(OR 1.11,95%CI 1.02-1.20)和VEGF-A(OR 1.18,95%CI 1.02-1.37)升高与脓毒症发病正相关。
- 遗传预测的CST5(OR 0.81,95%CI 0.69-0.94)和MCP-1(OR 0.64,95%CI 0.45-0.92)升高与脓毒症诱导死亡负相关。
- 作者认为这些蛋白可能是治疗干预的潜在靶点,但需进一步研究机制和临床意义。
适用人群与场景
- 遗传工具来自11个队列14,824名欧洲参与者的全基因组关联研究荟萃分析。
- 结局数据来自英国生物银行50万以上欧洲参与者的多中心前瞻性队列。
- 分析按年龄、28天死亡率和ICU入住进行分层。
研究设计与关键结果
- 研究类型为两样本孟德尔随机化研究,使用逆方差加权、MR-Egger和加权中位数多种方法。
- 遗传预测的β-NGF升高与脓毒症风险降低相关(OR 0.77,95%CI 0.60-0.99,P=0.039)。
- 在75岁以下脓毒症患者中,遗传预测的β-NGF升高与风险降低30%相关(OR 0.70,95%CI 0.52-0.93,P=0.013)。
- 遗传预测的TRAIL升高与脓毒症发病正相关(OR 1.11,95%CI 1.02-1.20,P=0.020)。
- 遗传预测的VEGF-A升高与脓毒症发病正相关(OR 1.18,95%CI 1.02-1.37,P=0.031)。
- 遗传预测的CST5升高与脓毒症诱导死亡负相关(OR 0.81,95%CI 0.69-0.94,P=0.006)。
- 遗传预测的MCP-1升高与脓毒症诱导死亡负相关(OR 0.64,95%CI 0.45-0.92,P=0.015)。
证据类型、等级与局限
- 证据类型为孟德尔随机化研究。
- 作者指出需进一步研究这些蛋白的潜在机制和临床意义。
对床旁实践的改变
- 作者认为这些发现支持特定循环炎症蛋白在脓毒症风险和死亡率中的因果作用,并提示靶向这些蛋白的治疗干预可能降低脓毒症风险、改善患者结局。
- 作者指出需进一步研究这些蛋白的潜在机制和临床意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective: Sepsis represents a leading cause of global mortality, defined by a dysregulated inflammatory response. This study aims to investigate the potential causal associations between circulating inflammatory proteins and sepsis risk using a two-sample Mendelian randomization (MR) approach. Methods: Publicly available summary statistics from genomewide association studies (GWAS) were used in this study. Genetic instruments for circulating inflammatory protein were derived from a GWAS meta-analysis of 11 cohorts encompassing 14,824 European participants. The relationship between genetically predicted protein levels and sepsis-related outcomes was evaluated using aggregated data from the UK Biobank-a multicenter prospective cohort study comprising over 500,000 European participants. Analyses were stratified by age, 28-day mortality, and ICU admission. Multiple MR methods, including inverse-variance weighted (IVW), MR-Egger, and weighted median, were applied to ensure the robustness of our findings. Results: The MR analysis identified significant causal associations between inflammatory proteins and sepsis outcomes. Genetically predicted elevated levels of β-NGF are associated with a reduced risk of sepsis (odds ratio [OR] 0.77, 95% confidence interval [CI] = 0.60-0.99; P = 0.039). Among sepsis patients aged below 75 years, the risk was reduced by 30% (OR, 0.70; 95% CI = 0.52-0.93; P = 0.013). Genetically predicted increases in TRAIL (OR, 1.11; 95% CI = 1.02-1.20; P = 0.020) and VEGF-A (OR, 1.18; 95% CI = 1.02-1.37; P = 0.031) were positively associated with sepsis incidence, while genetically predicted levels of CST5 (OR, 0.81; 95% CI = 0.69-0.94; P = 0.006) and MCP-1 (OR, 0.64; 95% CI = 0.45-0.92; P = 0.015) were inversely associated with sepsis-induced mortality. Conclusion: This study provides evidence from a Mendelian randomization framework supporting the causal role for specific circulating inflammatory proteins (e.g., β-NGF, VEGF-A, and TRAIL) in influencing sepsis risk and mortality. These findings underscore the potential for therapeutic interventions targeting these proteins to mitigate sepsis risk and improve patient outcomes, along with further investigation into the underlying mechanisms and clinical implications.
参考来源
- Ma H, Wang W, Tang B, et al. INFLAMMATORY PROTEIN SIGNATURES OF SEPSIS RISK AND MORTALITY: A MENDELIAN RANDOMIZATION STUDY. Shock. 2025. PMID: 40267509. doi:10.1097/SHK.0000000000002599
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。